Previous
Previous Product Image

Oakstone Addiction Medicine for Non-Specialists 2019

30 $
Next

The Aesthetic Blueprint Digital Library 2019

30 $
Next Product Image

The Passmachine Addiction Medicine Board Review Course 2018

20 $

+ Include: 36 videos + 36 pdfs, size: 10.8 GB

+ Target Audience: addiction medicine physicians

Categories: ,

Description

+ Include: 36 videos + 36 pdfs, size: 10.8 GB

+ Target Audience: addiction medicine physicians

+ Sample video: contact me for sample video

+ Topics:

01 Cocaine Use Disorders.mp4
01 Cocaine Use Disorders.pdf
02 Pharmacotherapy of Alcohol Dependence.mp4
02 Pharmacotherapy of Alcohol Dependence.pdf
02 Pharmacotherapy of Alcohol Use Disorders.mp4
02 Pharmacotherapy of Alcohol Use Disorders.pdf
03 Nicotine, Tobacco, and Cannabis Use Disorders.mp4
03 Nicotine, Tobacco, and Cannabis Use Disorders.pdf
04 Substance-Related Disorders SedativesHypnotic Use Disorders Amphetamine & Other Stimulants Use Disorders.mp4
04 Substance-Related Disorders SedativesHypnotic Use Disorders Amphetamine & Other Stimulants Use Disorders.pdf
05A Adolescents and Young Adults – Part 1.mp4
05A Adolescents and Young Adults – Part 1.pdf
05B Adolescents and Young Adults – Part 2.mp4
05B Adolescents and Young Adults – Part 2.pdf
05C Adolescents and Young Adults – Part 3.mp4
05C Adolescents and Young Adults – Part 3.pdf
06A Managing Pain in Patients with Addiction – Part 1.mp4
06A Managing Pain in Patients with Addiction – Part 1.pdf
06B Managing Pain in Patients with Addiction – Part 2.mp4
06B Managing Pain in Patients with Addiction – Part 2.pdf
07A Other Classes of Drug Use Disorders – Part 1.mp4
07A Other Classes of Drug Use Disorders – Part 1.pdf
07B Other Classes of Drug Use Disorders – Part 2.mp4
07B Other Classes of Drug Use Disorders – Part 2.pdf
08A Psychiatric Co-Morbidities – Part 1.mp4
08A Psychiatric Co-Morbidities – Part 1.pdf
08B Psychiatric Co-Morbidities – Part 2.mp4
08B Psychiatric Co-Morbidities – Part 2.pdf
09A Motivational Interviewing – Part 1.mp4
09A Motivational Interviewing – Part 1.pdf
09B Motivational Interviewing – Part 2.mp4
09B Motivational Interviewing – Part 2.pdf
10 Pharmacologic Treatment of Alcohol Withdrawal.mp4
10 Pharmacologic Treatment of Alcohol Withdrawal.pdf
11A Opioid Use Disorders – Part 1.mp4
11A Opioid Use Disorders – Part 1.pdf
11B Opioid Use Disorders – Part 2.mp4
11B Opioid Use Disorders – Part 2.pdf
12 Medical Co-Morbidities in the Substance Using Patient.mp4
12 Medical Co-Morbidities in the Substance Using Patient.pdf
13 Physiology of Addiction, Pharmacokinetic and Pharmacodynamic Principles.mp4
13 Physiology of Addiction, Pharmacokinetic and Pharmacodynamic Principles.pdf
14 Overview of Addiction Treatment.mp4
14 Overview of Addiction Treatment.pdf
15 Screening, Assessment, and Brief Intervention.mp4
15 Screening, Assessment, and Brief Intervention.pdf
16 Cognitive Behavior Therapy, Psychotherapy.mp4
16 Cognitive Behavior Therapy, Psychotherapy.pdf
17 Behavioral Interventions.mp4
17 Behavioral Interventions.pdf
18 Pregnancy and Women’s Health.mp4
18 Pregnancy and Women’s Health.pdf
19 Review of DSM-5 Substance Use Disorders.mp4
19 Review of DSM-5 Substance Use Disorders.pdf
20 Neurobiology of Addiction.mp4
20 Neurobiology of Addiction.pdf
21 Genetics of Substance Use Disorders.mp4
21 Genetics of Substance Use Disorders.pdf
22 Addiction and the Elderly.mp4
22 Addiction and the Elderly.pdf
23 Addiction in the Workplace.mp4
23 Addiction in the Workplace.pdf
24 Epidemiological Concepts and Trends of Substance Abuse Disorders.mp4
24 Epidemiological Concepts and Trends of Substance Abuse Disorders.pdf
25 Prevention and Public Health.mp4
25 Prevention and Public Health.pdf
26 Ethical Issues in Addiction Practice.mp4
26 Ethical Issues in Addiction Practice.pdf
27 Addiction Medicine and the Law.mp4
27 Addiction Medicine and the Law.pdf
28 Clinical and Legal Considerations in Drug Testing.mp4
28 Clinical and Legal Considerations in Drug Testing.pdf

Reviews

There are no reviews yet.

Be the first to review “The Passmachine Addiction Medicine Board Review Course 2018”

Your email address will not be published.